Alkem Laboratories Limited has informed the Exchange about Change in Conference Call Participants
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has informed the exchanges about a change in the list of participants for its Q3FY26 and 9MFY26 earnings conference call, scheduled for Friday, February 13, 2026 at 5:00 pm IST. This is a revision to its earlier intimation dated February 12, 2026. The call will be hosted by Motilal Oswal Securities and will be attended by senior company leadership, including Mr. Sandeep Singh (Managing Director), Dr. Vikas Gupta (CEO, Alkem Laboratories), Mr. Nitin Agrawal (CFO), and Mr. Kaustav Banerjee (CEO, Alkem MedTech). The call follows the announcement of the company's Q3 and 9MFY26 financial results on the same day. Dial-in details for domestic and international participants have been provided.
This is a routine procedural update with no material impact on the business or shareholders. It simply confirms the senior management lineup for the upcoming earnings call, signalling that the top leadership including MD, CEO, CFO, and MedTech CEO will be present to address investor questions.